Amy Pooler
Corporate Officer/Principal bei SANGAMO THERAPEUTICS, INC.
Vermögen: 110 047 $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Amy Pooler
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 15 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Amy Pooler
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
ALLERGAN, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ANTARES PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
University of Nebraska | College/University | Undergraduate Degree | |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
EMERGENT BIOSOLUTIONS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Masters Business Admin Doctorate Degree | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
University of California, Berkeley | College/University | Doctorate Degree Graduate Degree | |
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Biotechnology | General Counsel | |
ACCELERON PHARMA INC. | Biotechnology | Director/Board Member | |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Mariana Oncology, Inc.
Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | Biotechnology | Director/Board Member | |
University of California, Los Angeles | College/University | Doctorate Degree | |
EMYRIA LIMITED | Packaged Software | Director/Board Member | |
Humanetics Corp.
Humanetics Corp. Pharmaceuticals: MajorHealth Technology Humanetics Corp. engages in development and commercialization of bioactive compounds. Its products include radiation modulators, mechanism of action, safety and toxicology, and pharmacokinetics. It focuses on oncology, medical imaging, and medical countermeasures. The company was founded by Ronald J. Zenk in 1988 and is headquartered in Edina, MN. | Pharmaceuticals: Major | Director/Board Member | |
Medeor Therapeutics, Inc.
Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | Medical/Nursing Services | Chief Executive Officer | |
Curtin University of Technology | College/University | Undergraduate Degree | |
SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
FORWARD PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
University of Salford | College/University | Graduate Degree | |
University of New England (Australia) | College/University | Masters Business Admin | |
The University of Western Australia | College/University | Doctorate Degree | |
University of Warwick | College/University | Doctorate Degree | |
JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Cour Pharmaceuticals Development Co., Inc.
Cour Pharmaceuticals Development Co., Inc. BiotechnologyHealth Technology Cour Pharmaceuticals Development Co., Inc. engages in the development of therapies designed to reprogram the immune system to achieve antigen-specific tolerance for immune-mediated disease. Its product pipeline include celiac disease, peanut allergy, multiple sclerosis, and neutralizing antibodies. The company was founded by John J. Puisis and Jim Herrmann and is headquartered in Chicago, IL. | Biotechnology | Director/Board Member | |
Beyond Cancer, Ltd.
Beyond Cancer, Ltd. BiotechnologyHealth Technology Beyond Cancer, Ltd. is a development-stage biopharmaceutical and Bermudian medical device company that utilizes a proprietary delivery platform to treat primary tumors and prevent metastatic disease. The private company is based in Hamilton, Bermuda. Beyond Cancer is currently conducting a first-in-human study in patients with solid tumors and is focused on next level immuno-oncology. The CEO of the company is Selena A. Chaisson. | Biotechnology | Director/Board Member | |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company based in San Diego, CA. Capstan Therapeutics aims to multiply the therapeutic possibilities for patients by developing targeted in vivo RNA technologies. The company's platform technology, TLNPs, is designed to deliver payloads and gene editing tools to reprogram specific cell types in vivo. This technology has the potential to generate transformative therapies for various disease areas, including autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. Capstan Therapeutics, Inc. was founded in 2022 by Haig Aghajanian. Laura K. Shawver has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Director/Board Member | |
QUINCE THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
ARCTURUS THERAPEUTICS HOLDINGS INC. | Pharmaceuticals: Major | Director/Board Member | |
University of Texas at Austin | College/University | Undergraduate Degree | |
Sigma-Aldrich, Inc.
Sigma-Aldrich, Inc. Chemicals: Major DiversifiedProcess Industries Part of Merck KGaA, Sigma-Aldrich, Inc. is a company that offers a broad range of products and services for research, development, manufacturing, formulation, and quality control. The company is based in Milwaukee, WI. The company's portfolio includes products for pharmaceutical development and manufacturing, as well as a fully integrated service organization to support cdmo and contract testing across traditional and novel modalities. Sigma-Aldrich is also a trusted worldwide provider of innovative solutions in CRISPR/Cas9 products and services, custom products and services, including DNA oligos, RNA, siRNA, and custom peptides. The company offers exclusive savings on a handpicked selection of premium products at unbeatable prices and provide an easy way to quickly purchase products used often. | Chemicals: Major Diversified | Corporate Officer/Principal | |
John Hopkins University Atlantic Basin Policy Institute | College/University | Graduate Degree | |
San Diego State University | College/University | Masters Business Admin | |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
University of Bath | College/University | Undergraduate Degree | |
XOMA (US) LLC
XOMA (US) LLC Pharmaceuticals: MajorHealth Technology XOMA (US) LLC develops pharmaceutical preparations. It offers proprietary drugs and toiletries. The company is headquartered in Emeryville, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Delaware | College/University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 38 |
Australien | 4 |
Vereinigtes Königreich | 4 |
Singapur | 2 |
Dänemark | 2 |
Sektoral
Health Technology | 29 |
Consumer Services | 15 |
Commercial Services | 4 |
Technology Services | 2 |
Health Services | 2 |
Operativ
Director/Board Member | 65 |
Corporate Officer/Principal | 33 |
Independent Dir/Board Member | 26 |
Undergraduate Degree | 12 |
Chief Tech/Sci/R&D Officer | 11 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Karen Smith | 29 |
Robert Carey | 23 |
H. Parker | 22 |
Peg Horn | 12 |
Kenneth Hillan | 10 |
James Meyers | 9 |
Alexander Macrae | 7 |
John Markels | 7 |
Prathyusha Durabaibu | 5 |
Phillip Ramsey | 5 |
Courtney Beers | 4 |
Gregory Davis | 4 |
Scott Willoughby | 3 |
Louise Wilkie | 3 |
Nathalie Dubois Stringfellow | 2 |
- Börse
- Insiders
- Amy Pooler
- Unternehmensverbindungen